The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Personalizing treatment in patients with castrate-resistant prostate cancer: A study of predictive factors for secondary endocrine therapies activity.
Yohann Loriot
No relevant relationships to disclose
Christophe Massard
No relevant relationships to disclose
Laurence Albiges
No relevant relationships to disclose
Mario Di Palma
No relevant relationships to disclose
Pierre Blanchard
No relevant relationships to disclose
Alberto Bossi
No relevant relationships to disclose
Anne Chauchereau
No relevant relationships to disclose
Bernard J. Escudier
No relevant relationships to disclose
Karim Fizazi
No relevant relationships to disclose